Bespoke Extracts (BSPK) Cash from Operations Growth (3y) (2014 - 2025)
Bespoke Extracts (BSPK) Cash from Operations Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.72 Bn | 30.78 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.11 Bn | 20.96 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.88 Bn | 16.56 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 27.85% |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 68.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.45% |
| Jun 30, 2025 | -28.65% |
| Mar 31, 2025 | 30.77% |
| Nov 30, 2021 | 30.11% |
| Aug 31, 2021 | -30.37% |
| May 31, 2021 | -21.65% |
| Feb 28, 2021 | -54.22% |
| Nov 30, 2020 | -13.93% |
| May 31, 2020 | 33.33% |
| Feb 29, 2020 | -127.38% |
| Nov 30, 2019 | -21.38% |
| Aug 31, 2019 | -73.69% |
| May 31, 2019 | -40.11% |
| Feb 28, 2019 | -23.07% |
| Nov 30, 2018 | -12.73% |
| Aug 31, 2018 | -78.10% |
| May 31, 2018 | -62.70% |
| Feb 28, 2018 | -0.34% |
| Nov 30, 2017 | -36.92% |
| Aug 31, 2017 | -15.25% |